Mast-cell activation augments the late phase reaction in experimental immune-mediated blepharoconjunctivitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 5, 2003, Pages 394-402

  Ozaki, Akemi ^a   Fukushima, Atsuki ^a   Fukata, Kazuyo ^a   Ueno, Hisayuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOTAXIN; EYE DROPS; OVALBUMIN; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BLEPHARITIS; CELL ACTIVATION; CELL INFILTRATION; CELLULAR IMMUNITY; CONJUNCTIVA; CONJUNCTIVITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; EOSINOPHIL; HISTOPATHOLOGY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE MEDIATED INJURY; IMMUNOREACTIVITY; MALE; MAST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0038000579     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-003-0641-9     Document Type: Article

References (36)

1. Bischoff SC, Sellge G, Manns MP, et al (2001) Interleukin-4 induces a switch of human intestinal mast cells from proinflammatory cells to Th2-type cells. Int Arch Allergy Immunol 124:151-154
2. Bonini S, Ghinelli E (2000) The early and late phase of the ocular allergic reaction. Acta Ophthalmol Scand 230:41
3. Calhoun WJ, Sedgwick J, Busse WW (1991) The role of eosinophils in the pathophysiology of asthma. Ann NY Acad Sci 629:62-72
4. Fukagawa K, Nakajima T, Tsubota K, et al (1999) Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 103:1220-1221
5. Fukushima A, Nishino K, Yoshida O, et al (1998) Characterization of the immunopathogenic responses to ovalbumin peptide 323-339 in experimental immune-mediated blepharoconjunctivitis in Lewis rats. Curr Eye Res 17:763-769
6. Fukushima A, Fukata K, Ozaki A, et al (2003) Exertion of the suppressive effects of IFN-γ on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase. Br J Ophthalmol (in press)
7. Gronneberg R, Strandberg K, Stalenheim G, et al (1981) Effect in man of anti-allergic drugs on the immediate and late phase cutaneous allergic reactions induced by anti-IgE. Allergy 36:201-208
8. Hamelmann E, Gelfand EW (2001) IL-5-induced airway eosinophilia - the key to asthma? Immunol Rev 179:182-191
9. Hingorani M, Calder V, Jolly G, et al (1998) Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 102:821-830
10. Iwamoto H, Nishino K, Magone TM, et al (2000) Experimental immune-mediated blepharoconjunctivitis in rats induced by immunization with ragweed pollen. Graefes Arch Clin Exp, Ophthalmol 238:346-351
11. John M, Hirst SJ, Jose PJ, et al (1997) Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J Immunol 158:1841-1847
12. Joss JD, Craig TJ (1999) Seasonal allergic conjunctivitis: overview and treatment update. J Am Osteopath Assoc 99:13-18
13. Kaplan AP, Kuna P (1998) Chemokines and the late-phase reaction. Allergy 53:27-32
14. Kobayashi T, Miura T, Haba T, et al (2000) An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol 164:3855-3861
15. Lebman DA, Coffman RL (1988) Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures. J Exp Med 168:853-862
16. Lewis SJ, Quinn MJ, Fennessy MR, Jarrott B (1986) The effects of intracerebroventricular administration of compound 48/80 on behaviour and regional brain amine concentrations in the rat. Neurosci Lett 65:84-88
17. Li Q, Luyo D, Hikita N, et al (1996) Compound 48/80-induced conjunctivitis in the mouse: kinetics, susceptibility, and mechanism. Int Arch Allergy Immunol 109:277-285
18. Maggi E, Biswas P, Del Prete G, et al (1991) Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 146:1169-1174
19. Magone MT, Chan CC, Rizzo LV, et al (1998) A novel murine model of allergic conjunctivitis. Clin Immunol Immunopathol 87:75-84
20. Martin JG, Xu LJ, Toh MY, et al (1993) Leukotrienes in bile during the early and the late airway responses after allergen challenge of sensitized rats. Am Rev Respir Dis 147:104-110
21. Misawa M, Takenouchi K, Shirakawa Y, et al (1987) Effects of mast cell stabilizers on a new bronchial asthma model using compound 48/80 in dogs. Jpn J Pharmacol 44:197-205
22. Miyamasu M, Misaki Y, Yamaguchi M, et al (2000) Regulation of human eotaxin generation by Th1-/Th2-derived cytokines. Int Arch Allergy Immunol 122:54-58
23. Nagai H, Abe T, Yamaguchi I, et al (2000) Role of mast cells in the onset of IgE-mediated late-phase cutaneous response in mice. J Allergy Clin Immunol 106:91-98
24. Noviski N, Brewer JP, Skomik WA, et al (1999) Mast cell activation is not required for induction of airway hyperresponsiveness by ozone in mice. J Appl Physiol 86:202-210
25. Ozaki A, Fukushima A, Fukata K, et al (2000) Effects of IL-4 and IL-12 on experimental immune-mediated blepharoconjunctivitis in Brown Norway rats. Clin Exp Immunol 122:28-34
26. Pradalier A (1993) Late-phase reaction in asthma: basic mechanisms. Int Arch Allergy Immunol 101:322-325
27. Rioux F, Kerouac R, St-Pierre S (1985) Potency of various peptides as histamine liberators in the rat hind limb. Neuropeptides 6:311-319
28. Romagnani S (2001) T-cell responses in allergy and asthma. Curr Opin Allergy Clin Immunol 1:73-78
29. Rothenberg ME, MacLean JA, Pearlman E, et al (1997) Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 185:785-790
30. Sengoku T, Sato S, Sakuma S, et al (2001) Characterization of Ascaris-induced biphasic skin allergic reaction model in mice: possible roles of mast cells in early-phase and CD4-positive T cells in late-phase reactions. Pharmacology 63:82-89
31. Teixeira MM, Wells TN, Lukacs NW, et al (1997) Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest 100:1657-1666
32. Teran LM (2000) CCL chemokines and asthma. Immunol Today 21:235-242
33. Tonnel AB, Gosset P, Molet S, et al (1996) Interactions between endothelial cells and effector cells in allergic inflammation. Ann N Y Acad Sci. 31;796:9-20
34. Yamada N, Kadowaki S, Umezu K (1992) Development of an animal model of late asthmatic response in guinea pigs and effects of anti-asthmatic drugs. Prostaglandins 43:507-521
35. Ying S, Meng Q, Zeibecoglou K, et al (1999) Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 163:6321-6329
36. Yoshida O, Yoshida H, Iwamoto H, et al (1999) Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr Eye Res 18:117-124